Susquehanna International Group, LLP Bridge Bio Pharma, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$23.91 - $31.3 $3.51 Million - $4.59 Million	146,800 Added 4.91%	3,138,000 $79.9 Million
Q2 2024 Aug 15, 2024	BUY	$23.0 - $31.04 $45.7 Million - $61.6 Million	1,985,600 Added 197.45%	2,991,200 $75.8 Million
Q1 2024 May 07, 2024	BUY	$27.35 - $40.45 $7.14 Million - $10.6 Million	261,000 Added 35.05%	1,005,600 $31.1 Million
Q4 2023 Feb 14, 2024	BUY	$24.02 - $43.89 $2.49 Million - $4.55 Million	103,700 Added 16.18%	744,600 $30.1 Million
Q3 2023 Nov 14, 2023	SELL	$16.89 - $35.01 $3.44 Million - $7.12 Million	-203,400 Reduced 24.09%	640,900 $16.9 Million
Q2 2023 Aug 11, 2023	BUY	$13.29 - $18.01 $8.02 Million - $10.9 Million	603,100 Added 250.04%	844,300 $14.5 Million
Q1 2023 May 16, 2023	BUY	$7.17 - $18.55 $1.34 Million - $3.45 Million	186,200 Added 338.55%	241,200 $4 Million
Q4 2022 Feb 14, 2023	BUY	$6.74 - $11.52 $208,940 - $357,120	31,000 Added 129.17%	55,000 $419,000
Q3 2022 Nov 14, 2022	SELL	$7.94 - $12.36 $1.96 Million - $3.05 Million	-247,100 Reduced 91.15%	24,000 $239,000
Q2 2022 Aug 15, 2022	BUY	$5.21 - $12.14 $586,646 - $1.37 Million	112,600 Added 71.04%	271,100 $2.46 Million
Q1 2022 May 16, 2022	SELL	$7.34 - $17.16 $4.89 Million - $11.4 Million	-666,700 Reduced 80.79%	158,500 $1.61 Million
Q4 2021 Feb 14, 2022	BUY	$11.38 - $53.41 $8.67 Million - $40.7 Million	761,900 Added 1203.63%	825,200 $13.8 Million
Q3 2021 Nov 15, 2021	SELL	$46.87 - $64.24 $956,148 - $1.31 Million	-20,400 Reduced 24.37%	63,300 $2.97 Million
Q2 2021 Aug 11, 2021	SELL	$46.47 - $63.93 $989,811 - $1.36 Million	-21,300 Reduced 20.29%	83,700 $5.1 Million
Q1 2021 May 17, 2021	BUY	$55.47 - $72.35 $1.48 Million - $1.93 Million	26,700 Added 34.1%	105,000 $6.47 Million
Q4 2020 Feb 16, 2021	BUY	$38.38 - $71.11 $2.51 Million - $4.66 Million	65,500 Added 511.72%	78,300 $5.57 Million
Q3 2020 Nov 16, 2020	SELL	$27.2 - $42.19 $8 Million - $12.4 Million	-294,300 Reduced 95.83%	12,800 $480,000
Q2 2020 Aug 14, 2020	BUY	$22.22 - $35.69 $2.35 Million - $3.78 Million	105,900 Added 52.63%	307,100 $10 Million
Q1 2020 May 15, 2020	BUY	$16.11 - $36.23 $3.24 Million - $7.29 Million	201,200 New	201,200 $5.84 Million

Others Institutions Holding BBIO

# of Institutions

291

Shares Held

171M

Call Options Held

10.4M

Put Options Held

2.37M

Kohlberg Kravis Roberts & Co. L.P. New York, NY

25.3M
Shares

$599 Million
35.94% of portfolio
Viking Global Investors LP

25.1M
Shares

$596 Million
2.47% of portfolio
Vanguard Group Inc Valley Forge, PA

14.2M
Shares

$337 Million
0.01% of portfolio
Black Rock Inc. New York, NY

12.4M
Shares

$295 Million
0.01% of portfolio
Aisling Capital Management LP New York, NY

6.07M
Shares

$144 Million
63.58% of portfolio

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.52B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account